Biora Therapeutics, Inc.
TREATMENT OF A DISEASE OF THE GASTROINTESTINAL TRACT WITH GLATIRAMER OR A PHARMACEUTICALLY ACCEPTABLE SALT THEREOF
Last updated:
Abstract:
This disclosure features methods and compositions for treating diseases of the gastrointestinal tract with glatiramer or a pharmaceutically acceptable salt thereof, such as glatiramer acetate).
Status:
Application
Type:
Utility
Filling date:
13 Aug 2018
Issue date:
1 Oct 2020